Ligand
LGND
Performance
About Ligand
Ligand Pharmaceuticals is a biopharmaceutical investment and licensing company focused on advancing genetic medicines and high-value medicines through capital partnerships and a diversified portfolio of royalties. The company manages a large catalog of partnered and in-development programs across cancer, kidney disease, diabetes, nonalcoholic steatohepatitis, and rare conditions, with operations spanning global markets. It also licenses and maintains technology platforms such as Captisol and NITRICIL that support drug development for a wide network of biopharmaceutical partners. Ligand emphasizes both pharmaceutical royalties and strategic investments to accelerate clinical development and commercialization of medicines worldwide.